Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Biostem Technologies Inc (OP: BSEM ) 8.780 UNCHANGED Streaming Delayed Price Updated: 2:44 PM EDT, Aug 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 13,255 Open 8.780 Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 8.780 Today's Range 8.780 - 8.800 52wk Range 1.210 - 15.50 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News BioStem Technologies Innovative Wound-Care Treatments Steepen Its Growth Trajectory ($BSEM) July 16, 2024 Via AB Newswire Exposures Product Safety BioStem Technologies Inc. In A Race To The Top With Innovative Wound-Care Treatments ($BSEM) July 15, 2024 Via AB Newswire Topics Intellectual Property Exposures Intellectual Property Product Safety Performance YTD +44.53% +44.53% 1 Month -7.48% -7.48% 3 Month +2.62% +2.62% 6 Month -3.09% -3.09% 1 Year +387.78% +387.78% More News Read More BioStem Technologies Announces Opening of First Clinical Site for Diabetic Foot Ulcer Study October 24, 2023 Via ACCESSWIRE BioStem Technologies to Highlight Core Advanced Wound Care Portfolio at SAWC Fall 2023 Conference October 17, 2023 Via ACCESSWIRE BioStem Technologies: CMS Decision a “Win For Patients” September 29, 2023 Via ACCESSWIRE BioStem Receives IRB Approval for Clinical Study to Evaluate Vendaje(R) in Diabetic Foot Ulcers September 26, 2023 Via ACCESSWIRE BioStem Technologies Initiates Nationwide Launch of AmnioWrap2(TM) with Venture Medical September 19, 2023 Via ACCESSWIRE BioStem Technologies Engages PCG Advisory for Strategic Investor Relations September 18, 2023 Via ACCESSWIRE NovaBay Pharmaceuticals Announces Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova® Allograft September 11, 2023 From NovaBay Pharmaceuticals, Inc. Via Business Wire How BioStem Plans To Grow Its Perinatal Allografts In 2023 – And Beyond January 30, 2023 Via Benzinga 2022 Year in Review: BioStem Technologies Looks Back At A Year of Growth And Expansion January 13, 2023 Via Benzinga BioStem Technologies Announces Partnership with Kill Cliff FC December 14, 2022 From BioStem Technologies, Inc. Via GlobeNewswire BioStem Technologies Reports Third Quarter 2022 Operating and Financial Results November 15, 2022 From BioStem Technologies, Inc. Via GlobeNewswire BioStem Technologies to Host Third Quarter Financial Results and Corporate Update Conference Call November 15, 2022 From BioStem Technologies, Inc. Via GlobeNewswire BioStem Promotes Michael Fortunato, CPA to Chief Financial Officer October 26, 2022 From BioStem Technologies, Inc. Via GlobeNewswire BioStem to Present at the Dawson James Securities 2022 Small Cap Growth Conference October 10, 2022 From BioStem Technologies, Inc. Via GlobeNewswire BioStem Technologies (OTCMKTS: BSEM) Coverage Initiated at Zacks Investment Research September 22, 2022 Via Benzinga EXCLUSIVE: BioStem Technologies Reports Q1 Net Revenue Up 211% YoY May 16, 2022 Via Benzinga Cannabis Movers & Shakers: Halo Collective, Suite 420 Access, OWP, BioStem, Chicago Atlantic Advisors, Silo Wellness April 22, 2021 Via Benzinga Topics Cannabis Exposures Cannabis Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.